Canaccord Genuity Starts Obalon Therapeutics (OBLN) at Buy

October 31, 2016 7:54 AM EDT
Get Alerts OBLN Hot Sheet
Price: $11.31 +0.18%

Rating Summary:
    4 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 23 | Down: 34 | New: 34
Trade OBLN Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Canaccord Genuity initiated coverage on Obalon Therapeutics (NASDAQ: OBLN) with a Buy rating and a price target of $17.00.

For an analyst ratings summary and ratings history on Obalon Therapeutics click here. For more ratings news on Obalon Therapeutics click here.

Shares of Obalon Therapeutics closed at $13.80 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

New Coverage

Related Entities

Canaccord Genuity

Add Your Comment